Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

$31.99 0.30 (0.93%)

16:00 EST AMPH Stock Quote Delayed 30 Minutes

AMPH Stock Earnings: Amphastar Pharma Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings Aug 7, 2024

AMPH stock results show that Amphastar Pharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

7 Biotech Stocks to Buy on the Dip: June 2024

Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade

AMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024

Volume:

Previous Close -

Market Cap 1.54B

PE Ratio 10.63

EPS 3.01

Volume (Avg. Vol.) 575,644

Day's Range $31.87 - $32.56

52-Week Range $30.34 - $56.38

Dividend & Yield N/A (N/A)

AMPH Stock Predictions, Articles, and Amphastar Pharmaceuticals, Inc. - Common Stock News

3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Feb 5, 2024

As the new business cycle gets started, here are some biotech stocks with potential that investors should pay attention to.

3 Stocks at the Forefront of Medical Innovation

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Dec 25, 2023

Boring businesses and industries typically show new faces when technology comes around; today, these biotech stocks are leading the way.

7 Healthcare Stocks That Are Poised to Become the Next Unicorns

By Chandler Capital, InvestorPlace Contributor Nov 9, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

7 Safe Stocks to Rely on When the Market Swerves

By Louis Navellier and the InvestorPlace Research Staff Sep 19, 2022

Nevertheless, the discouraging prospect of more pain ahead doesn't mean you need to sit in cash. Your better option is to stay invested, but go on the defensive. You can achieve this, by focusing on names like these seven safe stocks. Each one is likely to see their resiliency continue in this down market.

7 Safe Small-Cap Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff May 12, 2022

If you're looking for resilient plays with high upside potential, consider these seven safe small-cap stocks to buy.

7 “A”-Rated Stocks to Ground Your Portfolio

By Louis Navellier and the InvestorPlace Research Staff Mar 17, 2022

It's a good time to make sure you have "A"-rated stocks in your portfolio. Many of the ones here have my triple-"A" rating.

7 Safe Stocks to Rely On When the Market Swerves

By Louis Navellier and the InvestorPlace Research Staff Feb 9, 2022

When markets that have flown so high for so long start to tumble, along with an economy that transitioning, safe stocks are essential.

7 Stocks to Buy for June

By James Brumley, InvestorPlace Feature Writer May 28, 2019

TerraForm Power, Zillow Group and Boston Scientific are just some of the top stocks to buy as May turns into June.

3 Stocks to Watch on Tuesday: Amphastar Pharmaceuticals Inc (AMPH), Coupa Software Inc (COUP) and Kronos Worldwide, Inc. (KRO)

By Karl Utermohlen, InvestorPlace Writer Mar 13, 2018

Amphastar Pharmaceuticals (AMPH), Coupa Software (COUP) and Kronos Worldwide (KRO) reported on their quarterly earnings after the bell Monday.

Why Seattle Genetics, Inc. (SGEN), Endologix, Inc. (ELGX) and Amphastar Pharmaceuticals Inc (AMPH) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Dec 27, 2016

Owners of healthcare stocks Endologix (ELGX), Amphastar Pharmaceuticals (AMPH) and Seattle Genetics (SGEN) each had a run of bad luck on Tuesday.

Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

AMPH Stock Earnings: Amphastar Pharma Beats EPS, Beats Revenue for Q2 2024

7 Biotech Stocks to Buy on the Dip: June 2024

Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade

AMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AMPH Stock Predictions, Articles, and Amphastar Pharmaceuticals, Inc. - Common Stock News

Subscriber Sign in